Danielle Chau, MD
Gynecologic Oncology · Norfolk, VANPI 1417301169
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,199 of the $1,703 with a category attached, or 70.4%. Intuitive Surgical accounts for 62.1% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $1,282 and has fallen 83.0% since, to $218 in 2024. That places this record below the midpoint for gynecologic oncology clinicians in VA, where the typical reported total is $1,719.
Across 9 payments — averaging $189.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- AstraZeneca$348
- Seagen Inc.$199
- Foundation Medicine, Inc.$98
What the payments were for
- Food & beverage$50430%
- Education$1,19970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $1,058 |
| AstraZeneca | 3 | $348 |
| Seagen Inc. | 2 | $199 |
| Foundation Medicine, Inc. | 1 | $98 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,000
- LYNPARZA$348
How this compares
$1,703 in reported general payments places this provider in the 45th percentile of 47 gynecologic oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $11,017 |
| Megestrol Acetate | 12 | $579 |
| Ondansetron OdtOndansetron | 28 | $382 |
| Prochlorperazine Maleate | 20 | $243 |
| Oxycodone Hcl | 31 | $140 |
| LoperamideLoperamide Hcl | 11 | $84 |
| Ibuprofen | 21 | $82 |
| Tramadol Hcl | 21 | $31 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Norfolk
- Devin MillerNorfolk$2K
- Camilla YuNorfolk$1K
- Robert SquatritoNorfolk$121
- Michael McCollumNorfolk$0
- Cecelia BoardmanRichmond$577K
- Leslie RandallFairfax$342K
- Chad HamiltonAnnandale$242K
- Samantha BatmanCharlottesville$76K
- Linda DuskaCharlottesville$72K
- Marilyn HuangCharlottesville$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.